NOV Inc. Quarterly Cost of Revenue in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NOV Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2018 to Q3 2024.
  • NOV Inc. Cost of Revenue for the quarter ending September 30, 2024 was $1.72B, a 0.29% increase year-over-year.
  • NOV Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $6.89B, a 5.46% increase year-over-year.
  • NOV Inc. annual Cost of Revenue for 2023 was $6.75B, a 14.3% increase from 2022.
  • NOV Inc. annual Cost of Revenue for 2022 was $5.9B, a 24.3% increase from 2021.
  • NOV Inc. annual Cost of Revenue for 2021 was $4.75B, a 16% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.89B $1.72B +$5M +0.29% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q2 2024 $6.89B $1.63B -$10M -0.61% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $6.9B $1.7B +$146M +9.41% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $6.75B $1.85B +$216M +13.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $6.53B $1.72B +$196M +12.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q2 2023 $6.34B $1.64B +$218M +15.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $6.12B $1.55B +$217M +16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $5.9B $1.63B +$315M +24% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $5.59B $1.52B +$365M +31.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $5.22B $1.42B +$232M +19.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $4.99B $1.33B +$241M +22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $4.75B $1.32B -$78M -5.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $4.83B $1.16B -$89M -7.15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $4.92B $1.19B -$173M -12.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $5.09B $1.09B -$566M -34.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $5.66B $1.39B -$512M -26.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $6.17B $1.25B -$730M -37% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $6.9B $1.36B -$711M -34.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $7.61B $1.66B -$25M -1.49% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $7.63B $1.91B -$84M -4.22% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $7.72B $1.98B +$214M +12.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 $7.5B $2.07B +$319M +18.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $7.19B $1.68B +$176M +11.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 $7.01B $1.99B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $1.76B Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $1.75B Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $1.51B Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.